RE:AGMThe landscape changed very much from the original April 22, 2020 agreement for the sale of OncoQuest assets to OncoQuest Pharmaceutical Inc, (OQP) (formerly Dual Industrial Co., Ltd.) and the subsequent news that followed. A very confusing state of affairs. The immunotherapy assets ownership seems to have leapfrogged from "OQP" to OncoQuest Pharmacetical US Inc. There was a discussion about a $140 Million (CAN) bond. Not clear as to who put it up and in whose favour. There was some talk about this getting monetized etc. Hard to understand what Dr. Madiyalakan was saying at times. A lot of confusing talks were ongoing.
Can anyone that phoned into the AGM shed some additional light on yesterday's events would be helpful. Hoping that the entire Q&A was recorded and will be published.
G1945V